Author:
Bayes Adam,Short Brooke,Zarate Carlos A.,Park Lawrence,Murrough James W.,McLoughlin Declan M.,Riva-Posse Patricio,Schoevers Robert,Veraart Jolien,Parikh Sagar,Glue Paul,Fam Johnson,McShane Rupert,Galvez Veronica,Martin Donel,Tor Phern-Chern,Brunoni Andre R.,Loo Colleen K.
Subject
Psychiatry and Mental health,Clinical Psychology
Reference18 articles.
1. Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis;Bahji;J. Affect. Disord.,2020
2. Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study;Canuso;Am. J. Psychiatry,2018
3. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial;Daly;JAMA Psychiatry,2019
4. Comments to Drs. Gastaldon, Raschi, Kane, Barbui, and Schoretsanitis;Doherty;Psychother. Psychosom.,2021
5. Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system;Gastaldon;Psychother. Psychosom.,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献